Post by Axmed

“𝐓𝐡𝐞 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐞𝐫𝐬 𝐚𝐫𝐞 𝐫𝐞𝐚𝐝𝐲. 𝐓𝐡𝐞 𝐛𝐮𝐲𝐞𝐫𝐬 𝐚𝐫𝐞 𝐯𝐢𝐠𝐢𝐥𝐚𝐧𝐭. 𝐓𝐡𝐞 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐬 𝐚𝐫𝐞 𝐭𝐫𝐲𝐢𝐧𝐠. 𝐒𝐨 𝐰𝐡𝐚𝐭 𝐢𝐬 𝐦𝐢𝐬𝐬𝐢𝐧𝐠?” In his article on medicine quality across East Africa, our Regulatory Affairs Manager, Dr. Onyango Michael, argues that the answer isn't greater effort from individual actors - it’s the connective tissue that allows quality information to flow across the system. Today, manufacturers are investing in stronger quality processes. Buyers are conducting independent verification. Regulators are pursuing harmonisation and new approaches to post-market surveillance. Yet too much of that intelligence remains isolated. A supplier's quality track record sits in one database, while a cold-chain incident lives in another. Procurement decisions are made without visibility into either. As Dr. Onyango explains, technology changes that dynamic. When quality performance becomes visible, verifiable, and shared, the incentives change. Quality stops being an obligation carried by individual actors and becomes a standard reinforced by the system itself. 📄 Read the full article now: https://lnkd.in/etjGStbY #AxmedVoices #HealthSystems #PharmaceuticalQuality